Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11494361rdf:typepubmed:Citationlld:pubmed
pubmed-article:11494361lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:11494361lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:11494361lifeskim:mentionsumls-concept:C2333134lld:lifeskim
pubmed-article:11494361lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:11494361lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:11494361lifeskim:mentionsumls-concept:C1415288lld:lifeskim
pubmed-article:11494361lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:11494361lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:11494361lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:11494361pubmed:issue3lld:pubmed
pubmed-article:11494361pubmed:dateCreated2001-8-8lld:pubmed
pubmed-article:11494361pubmed:abstractTextalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA-R)-mediated neurotoxicity was studied in relation to subunit expression and the presence of Ca(2+)-permeable receptor channels. AMPA-mediated toxicity had two components: 1) a direct AMPA-R-mediated component, which was not due to Ca(2+) influx through voltage-gated Ca(2+) channels, reversal of the Na(+)/Ca(2+) exchanger or release of calcium from dantrolene-sensitive intracellular Ca(2+) stores, and 2) a minor, indirect component involving activation of NMDA receptor channels, because of glutamate release and removal of the Mg(2+) block of the NMDA receptor on AMPA-R stimulation. The involvement of Ca(2+) influx through AMPA-R was also examined. The number of neurons possessing Ca(2+)-permeable AMPA-R increased during culture development, concurrently with an increasing susceptibility for AMPA-induced toxicity during development. GluR2(R) levels also increased during development, and channel blockers of Ca(2+)-permeable AMPA-R lacking the GluR2(R) subunit (spermine and philanthotoxin) failed to prevent neurotoxicity or increases in [Ca(2+)](i). Thus, the direct AMPA-R-mediated toxicity may be explained by initiation of cell death by Ca(2+) fluxing through AMPA-R containing GluR2(R). The components of direct AMPA-R-mediated toxicity are proposed to be 1) toxicity mediated by GluR2(R)-lacking AMPA-R and 2) toxicity mediated by low-Ca(2+)-permeability AMPA-R containing GluR2(R).lld:pubmed
pubmed-article:11494361pubmed:languageenglld:pubmed
pubmed-article:11494361pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:citationSubsetIMlld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11494361pubmed:statusMEDLINElld:pubmed
pubmed-article:11494361pubmed:monthAuglld:pubmed
pubmed-article:11494361pubmed:issn0360-4012lld:pubmed
pubmed-article:11494361pubmed:authorpubmed-author:SchousboeAAlld:pubmed
pubmed-article:11494361pubmed:authorpubmed-author:JensenJ BJBlld:pubmed
pubmed-article:11494361pubmed:authorpubmed-author:LundT MTMlld:pubmed
pubmed-article:11494361pubmed:authorpubmed-author:PickeringD...lld:pubmed
pubmed-article:11494361pubmed:authorpubmed-author:TimmermannD...lld:pubmed
pubmed-article:11494361pubmed:copyrightInfoCopyright 2001 Wiley-Liss, Inc.lld:pubmed
pubmed-article:11494361pubmed:issnTypePrintlld:pubmed
pubmed-article:11494361pubmed:day1lld:pubmed
pubmed-article:11494361pubmed:volume65lld:pubmed
pubmed-article:11494361pubmed:ownerNLMlld:pubmed
pubmed-article:11494361pubmed:authorsCompleteYlld:pubmed
pubmed-article:11494361pubmed:pagination267-77lld:pubmed
pubmed-article:11494361pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:meshHeadingpubmed-meshheading:11494361...lld:pubmed
pubmed-article:11494361pubmed:year2001lld:pubmed
pubmed-article:11494361pubmed:articleTitleRole of GluR2 expression in AMPA-induced toxicity in cultured murine cerebral cortical neurons.lld:pubmed
pubmed-article:11494361pubmed:affiliationThe Royal Danish School of Pharmacy, NeuroScience PharmaBiotech Research Center, Department of Pharmacology, 2 Universitetsparken, DK-2100 Copenhagen, Denmark.lld:pubmed
pubmed-article:11494361pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11494361pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed